brentuximab vedotin

Ligand id: 6772

Name: brentuximab vedotin

Bioactivity Comments
Detailed information contained in the covering patent [3] describes in vitro and in vivo activity of the invention, which supports its anti-CD30 action. However, no affinity data is provided for the interaction between the antibody and its molecular target.
Selectivity at human catalytic receptors
Key to terms and symbols Click column headers to sort
Target Type Action Affinity Units Concentration range (M) Reference
CD30 Antibody Inhibition - - -